U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 990

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:40690337-40690793
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BPathogenic
(May 29, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr17:40688291-40729741
MLX, COASY, HSD17B1, NAGLU, PSMC3IPCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(May 17, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr17:40689396-40690793
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BPathogenic
(Jun 2, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr17:40689450
GRCh38:
Chr17:42537432
NAGLUY140HMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely pathogenic
(Feb 21, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr17:40695297
GRCh38:
Chr17:42543279
NAGLUG425RMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(May 28, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr17:40695463
GRCh38:
Chr17:42543445
NAGLUA480VMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Feb 25, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr17:40690728
GRCh38:
Chr17:42538710
NAGLUP240LMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(May 12, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr17:40693233
GRCh38:
Chr17:42541215
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(Apr 17, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr17:40689397
GRCh38:
Chr17:42537379
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(May 7, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr17:40695415
GRCh38:
Chr17:42543397
NAGLUR464QMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Aug 19, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr17:40688507
GRCh38:
Chr17:42536489
NAGLUA73TMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Mar 5, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr17:40695114
GRCh38:
Chr17:42543096
NAGLUA364TCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Aug 14, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr17:40693102
GRCh38:
Chr17:42541084
NAGLUI300TMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V, not provided
Uncertain significance
(Sep 13, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr17:40690437
GRCh38:
Chr17:42538419
NAGLUM204ICharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Jul 26, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr17:40688678
GRCh38:
Chr17:42536660
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Sep 13, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr17:40688344
GRCh38:
Chr17:42536326
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(Aug 16, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr17:40689412
GRCh38:
Chr17:42537394
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Sep 23, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr17:40695646
GRCh38:
Chr17:42543628
NAGLUR541QCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Mar 3, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr17:40695147
GRCh38:
Chr17:42543129
NAGLUR375CCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr17:40688438
GRCh38:
Chr17:42536420
NAGLUV50LCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Mar 4, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr17:40695201
GRCh38:
Chr17:42543183
NAGLUR393CCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Aug 6, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr17:40690472
GRCh38:
Chr17:42538454
NAGLUP216HCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Dec 17, 2021)
criteria provided, single submitter
23.
GRCh37:
Chr17:40693159
GRCh38:
Chr17:42541141
NAGLUP319LCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BPathogenic
(Aug 9, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr17:40695028
GRCh38:
Chr17:42543010
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(Mar 21, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr17:40695164
GRCh38:
Chr17:42543146
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Sep 15, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr17:40695846
GRCh38:
Chr17:42543828
NAGLUE608QMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jun 23, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr17:40688670
GRCh38:
Chr17:42536652
NAGLUN127SMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Aug 23, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr17:40690693
GRCh38:
Chr17:42538675
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Oct 14, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr17:40695329
GRCh38:
Chr17:42543311
NAGLUN435KMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jul 25, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr17:40695433
GRCh38:
Chr17:42543415
NAGLUD470VMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Sep 22, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr17:40695520
GRCh38:
Chr17:42543502
NAGLUR499QMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Sep 24, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr17:40688329
GRCh38:
Chr17:42536311
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Jun 18, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr17:40688327
GRCh38:
Chr17:42536309
NAGLUL13FCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Nov 18, 2021)
criteria provided, single submitter
34.
GRCh37:
Chr17:40689559
GRCh38:
Chr17:42537541
NAGLUQ176RCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Aug 4, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr17:40688548
GRCh38:
Chr17:42536530
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Mar 28, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr17:40690730
GRCh38:
Chr17:42538712
NAGLUV241LCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr17:40688652
GRCh38:
Chr17:42536634
NAGLUL121PMucopolysaccharidosis, MPS-III-B, Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V
Uncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr17:40688453
GRCh38:
Chr17:42536435
NAGLUA55TMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(May 10, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr17:40695942
GRCh38:
Chr17:42543924
NAGLUQ640*Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VPathogenic
(Nov 28, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr17:40693182
GRCh38:
Chr17:42541164
NAGLUL327FMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Dec 23, 2021)
criteria provided, single submitter
41.
GRCh37:
Chr17:40689504
GRCh38:
Chr17:42537486
NAGLUA158SMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Aug 12, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr17:40688676
GRCh38:
Chr17:42536658
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jun 30, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr17:40688462
GRCh38:
Chr17:42536444
NAGLUA58PMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Sep 6, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr17:40688319-40688320
GRCh38:
Chr17:42536301-42536302
NAGLUV12fsMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VPathogenic
(Aug 5, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr17:40695741
GRCh38:
Chr17:42543723
NAGLUS573GMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V, Inborn genetic diseases
Uncertain significance
(Jun 21, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr17:40695622
GRCh38:
Chr17:42543604
NAGLUR533QCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Aug 13, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr17:40695564
GRCh38:
Chr17:42543546
NAGLUR514CInborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B
Uncertain significance
(Mar 4, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr17:40692985
GRCh38:
Chr17:42540967
NAGLUN261SCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Aug 23, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr17:40689442
GRCh38:
Chr17:42537424
NAGLUT137MMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Sep 17, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr17:40689478
GRCh38:
Chr17:42537460
NAGLUR149Lnot provided, Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V
Uncertain significance
(Feb 4, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr17:40690770
GRCh38:
Chr17:42538752
NAGLUT254IMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jul 23, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr17:40688316
GRCh38:
Chr17:42536298
NAGLUA9VMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jun 11, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr17:40688639
GRCh38:
Chr17:42536621
NAGLUV117LMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jul 14, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr17:40695372
GRCh38:
Chr17:42543354
NAGLUQ450EInborn genetic diseases, Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V
Uncertain significance
(Jun 30, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr17:40695278
GRCh38:
Chr17:42543260
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(Aug 31, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr17:40693188
GRCh38:
Chr17:42541170
NAGLUA329TMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr17:40693197
GRCh38:
Chr17:42541179
NAGLUT332AMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Oct 12, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr17:40688482
GRCh38:
Chr17:42536464
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(Sep 12, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr17:40695688
GRCh38:
Chr17:42543670
NAGLUA555VMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Apr 13, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr17:40688525
GRCh38:
Chr17:42536507
NAGLUG79SMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Apr 17, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr17:40695913
GRCh38:
Chr17:42543895
NAGLUV630GMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Aug 10, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr17:40690747
GRCh38:
Chr17:42538729
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(May 22, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr17:40695532
GRCh38:
Chr17:42543514
NAGLUN503SMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jun 20, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr17:40693165
GRCh38:
Chr17:42541147
NAGLUS321FMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jul 3, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr17:40695694
GRCh38:
Chr17:42543676
NAGLUR557HCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr17:40696078
GRCh38:
Chr17:42544060
NAGLUS685TCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Apr 25, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr17:40690468
GRCh38:
Chr17:42538450
NAGLUP215SMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(May 19, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr17:40695912
GRCh38:
Chr17:42543894
NAGLUV630IMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Apr 11, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr17:40690768
GRCh38:
Chr17:42538750
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(May 5, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr17:40689485
GRCh38:
Chr17:42537467
NAGLUE151DMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jun 14, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr17:40695939
GRCh38:
Chr17:42543921
NAGLUE639QMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jul 25, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr17:40690789
GRCh38:
Chr17:42538771
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(Apr 24, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr17:40695687
GRCh38:
Chr17:42543669
NAGLUA555TMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Aug 9, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr17:40690746
GRCh38:
Chr17:42538728
NAGLUA246EMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Dec 19, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr17:40688295
GRCh38:
Chr17:42536277
NAGLUE2GMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Aug 11, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr17:40696149
GRCh38:
Chr17:42544131
NAGLUV709IMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Sep 19, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr17:40688334
GRCh38:
Chr17:42536316
NAGLUL15PMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(Oct 7, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr17:40695728
GRCh38:
Chr17:42543710
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Jul 23, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr17:40696239
GRCh38:
Chr17:42544221
NAGLUV739MCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Apr 25, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr17:40695512
GRCh38:
Chr17:42543494
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(May 24, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr17:40695565
GRCh38:
Chr17:42543547
NAGLUR514HMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Aug 9, 2022)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr17:40693052
GRCh38:
Chr17:42541034
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Nov 15, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr17:40695506
GRCh38:
Chr17:42543488
NAGLUW494*Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VPathogenic
(Apr 23, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr17:40695044
GRCh38:
Chr17:42543026
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BPathogenic
(May 27, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr17:40690734
GRCh38:
Chr17:42538716
NAGLUL242PMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jun 26, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr17:40689489
GRCh38:
Chr17:42537471
NAGLUE153*Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VPathogenic
(Jan 21, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr17:40688525
GRCh38:
Chr17:42536507
NAGLUG79CMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VPathogenic
(Oct 28, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr17:40688434
GRCh38:
Chr17:42536416
NAGLUF48LMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VPathogenic
(Mar 22, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr17:40688402
GRCh38:
Chr17:42536384
NAGLUR38WMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V, Inborn genetic diseases,
not provided
Pathogenic/Likely pathogenic
(Nov 22, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr17:40688410
GRCh38:
Chr17:42536392
NAGLUMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VLikely benign
(May 11, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr17:40690488
GRCh38:
Chr17:42538470
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Apr 30, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr17:40695761-40695763
GRCh38:
Chr17:42543743-42543745
NAGLUR580delCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Aug 12, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr17:40689497
GRCh38:
Chr17:42537479
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Apr 24, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr17:40692983
GRCh38:
Chr17:42540965
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Apr 22, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr17:40690413
GRCh38:
Chr17:42538395
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Apr 30, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr17:40695245
GRCh38:
Chr17:42543227
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(May 9, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr17:40693089
GRCh38:
Chr17:42541071
NAGLUL296MCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BUncertain significance
(Oct 17, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr17:40689481
GRCh38:
Chr17:42537463
NAGLUW150*Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BPathogenic
(Apr 13, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr17:40695359
GRCh38:
Chr17:42543341
NAGLUCharcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-BLikely benign
(Apr 12, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr17:40688346
GRCh38:
Chr17:42536328
NAGLUG19EMucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2VUncertain significance
(Jul 14, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination